Ciclosporin reduces risk of diabetes following renal transplantation

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1553, 2006-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Economic Model of 2-Hour Post-Dose Ciclosporin Monitoring in Renal Transplantation

By Paul A. Keown   Bryce Kiberd  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Interaction between Levofloxacin and Ciclosporin or Tacrolimus in Kidney Transplant Recipients: Ciclosporin, Tacrolimus and Levofloxacin in Renal Transplantation

By Federico Stefano  

Clinical Pharmacokinetics, Vol. 45, Iss. 2, 2006-01 ,pp. : 169-175

Adis International

Access to resources Recommend Favorite

Tacrolimus warranted following renal transplantation

By  

Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Sirolimus reduces acute rejection in renal transplantation

By  

Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Daclizumab reduces corticosteroid burden in renal transplantation

By  

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite